BiotechTube

YH12852 0.1 mg + YH12852 0.25 mg + YH12852 0.5 mg + Placebo

Phase 2Terminated
0 watching 0 views this week⚡ Active
52
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Functional Dyspepsia

Conditions

Functional Dyspepsia

Trial Timeline

Oct 1, 2015 → Mar 16, 2017

NCT ID
NCT02567578

About YH12852 0.1 mg + YH12852 0.25 mg + YH12852 0.5 mg + Placebo

YH12852 0.1 mg + YH12852 0.25 mg + YH12852 0.5 mg + Placebo is a phase 2 stage product being developed by Yuhan for Functional Dyspepsia. The current trial status is terminated. This product is registered under clinical trial identifier NCT02567578. Target conditions include Functional Dyspepsia.

Hype Score Breakdown

Clinical
17
Activity
12
Company
10
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT02567578Phase 2Terminated

Competing Products

20 competing products in Functional Dyspepsia

See all competitors
ProductCompanyStageHype Score
YH12852 IR 0.05mg + YH12852 IR 0.1mg + YH12852 IR 0.3mg + YH12852 IR 0.5mg + YH12852 IR 1mg + YH12852 IR 2mg + YH12852 IR 3mg + YH12852 DR1 0.5mg + YH12852 DR1 1mg + YH12852 DR1 2mg + YH12852 DR1 4mg + YH12852 DR2 8mg + Prucalopride 2mg + PlaceboYuhanPhase 1/2
41
YM443 + Placebo + MoxifloxacinAstellas PharmaPhase 1
33
Rabeprazole + Rabeprazole + Rabeprazole + PlaceboEisaiPhase 2
52
Imonogas + EspumisanJohnson & JohnsonPhase 3
77
Linaclotide + PlaceboAbbViePhase 3
77
Linaclotide + Placebo for LinaclotideAbbViePhase 3
77
Linaclotide + PlaceboAbbViePhase 2
52
Quetiapine (50 mg/day-100mg/day)AstraZenecaPre-clinical
23
NKTR-118AstraZenecaPhase 1
33
PDR001NovartisPhase 2
52
Human GLP-1 (7-36) amide + Isotone NaClNovo NordiskPre-clinical
22
psyllium fibre (dietary supplement) + wheat bran (dietary supplement) + rice wheat (placebo)PfizerPre-clinical
22
Gabapentin + PlaceboPfizerPhase 3
76
Z-338Zeria PharmaceuticalPhase 2
51
Z-338 + PlaceboZeria PharmaceuticalPhase 3
76
Acotiamide hydrochloride hydrate + PlaceboZeria PharmaceuticalPhase 3
76
Z-338Zeria PharmaceuticalPhase 2
51
MibavademabRegeneron PharmaceuticalsPhase 2
51
STW5 (Iberogast®, BAY98-7411) + PlaceboBayerPhase 2
49
Iberogast (STW5-II, BAY98-7410)BayerPre-clinical
20

Other Products from Yuhan

generic formulation of atorvastatin (Atorva®) + branded formulation of atorvastatin (Lipitor®)Approved
85
Pregabalin 150mg + Alpha-lipoic acid 480mg + Pregabalin 150mg + Alpha-Lipoic Acid 480mgApproved
85
Anplag Tab. 100mg bid + Anplag Tab. 100mg tidApproved
85
Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg + Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mgApproved
85
Atorvastatin 20mg loading + Atorvastatin 80mg loadingApproved
85